221 related articles for article (PubMed ID: 28855144)
1. Heterotopic ossification: Mechanistic insights and clinical challenges.
Xu R; Hu J; Zhou X; Yang Y
Bone; 2018 Apr; 109():134-142. PubMed ID: 28855144
[TBL] [Abstract][Full Text] [Related]
2. A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings.
Amalfitano M; Fyfe B; Thomas SV; Egan KP; Xu M; Smith AG; Kaplan FS; Shore EM; Pignolo RJ
Bone; 2018 Apr; 109():56-60. PubMed ID: 29320714
[TBL] [Abstract][Full Text] [Related]
3. Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification.
Regard JB; Malhotra D; Gvozdenovic-Jeremic J; Josey M; Chen M; Weinstein LS; Lu J; Shore EM; Kaplan FS; Yang Y
Nat Med; 2013 Nov; 19(11):1505-12. PubMed ID: 24076664
[TBL] [Abstract][Full Text] [Related]
4. Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial.
Pacifici M
Bone; 2018 Apr; 109():267-275. PubMed ID: 28826842
[TBL] [Abstract][Full Text] [Related]
5. A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification.
Cong Q; Liu Y; Zhou T; Zhou Y; Xu R; Cheng C; Chung HS; Yan M; Zhou H; Liao Z; Gao B; Bocobo GA; Covington TA; Song HJ; Su P; Yu PB; Yang Y
Sci Transl Med; 2021 Jun; 13(599):. PubMed ID: 34162750
[TBL] [Abstract][Full Text] [Related]
6. Conserved signaling pathways underlying heterotopic ossification.
Kan C; Chen L; Hu Y; Ding N; Lu H; Li Y; Kessler JA; Kan L
Bone; 2018 Apr; 109():43-48. PubMed ID: 28455214
[TBL] [Abstract][Full Text] [Related]
7. Differential Vascularity in Genetic and Nonhereditary Heterotopic Ossification.
Ware AD; Brewer N; Meyers C; Morris C; McCarthy E; Shore EM; James AW
Int J Surg Pathol; 2019 Dec; 27(8):859-867. PubMed ID: 31250694
[No Abstract] [Full Text] [Related]
8. BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification.
Kan C; Ding N; Yang J; Tan Z; McGuire TL; Lu H; Zhang K; Berger DMP; Kessler JA; Kan L
Stem Cell Res Ther; 2019 Jan; 10(1):14. PubMed ID: 30635039
[TBL] [Abstract][Full Text] [Related]
9. Bone: Hedgehog signalling linked to heterotopic ossification in POH.
Buckland J
Nat Rev Rheumatol; 2013 Nov; 9(11):636. PubMed ID: 24126699
[No Abstract] [Full Text] [Related]
10. Launching lollipops? Perforating osteoma cutis in nephrogenic systemic fibrosis.
Moshiri AS; Elenitsas R; Gaddis KJ; Werth VP; Nguyen CV; Pearson D; Rubin AI
J Cutan Pathol; 2019 Jul; 46(7):467-470. PubMed ID: 31355484
[No Abstract] [Full Text] [Related]
11. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
[TBL] [Abstract][Full Text] [Related]
12. The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent.
Upadhyay J; Xie L; Huang L; Das N; Stewart RC; Lyon MC; Palmer K; Rajamani S; Graul C; Lobo M; Wellman TJ; Soares EJ; Silva MD; Hesterman J; Wang L; Wen X; Qian X; Nannuru K; Idone V; Murphy AJ; Economides AN; Hatsell SJ
J Bone Miner Res; 2017 Dec; 32(12):2489-2499. PubMed ID: 28782882
[TBL] [Abstract][Full Text] [Related]
13. Heterotopic Ossification: The Keys to the Kingdom.
Kaplan FS; Pignolo RJ; Shore EM
Bone; 2018 Apr; 109():1-2. PubMed ID: 29567209
[No Abstract] [Full Text] [Related]
14. Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification.
Pignolo RJ; Xu M; Russell E; Richardson A; Kaplan J; Billings PC; Kaplan FS; Shore EM
J Bone Miner Res; 2011 Nov; 26(11):2647-55. PubMed ID: 21812029
[TBL] [Abstract][Full Text] [Related]
15. Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling.
Wang H; Lindborg C; Lounev V; Kim JH; McCarrick-Walmsley R; Xu M; Mangiavini L; Groppe JC; Shore EM; Schipani E; Kaplan FS; Pignolo RJ
J Bone Miner Res; 2016 Sep; 31(9):1652-65. PubMed ID: 27027798
[TBL] [Abstract][Full Text] [Related]
16. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.
Ravazzolo R; Cappato S; Bocciardi R
Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956
[TBL] [Abstract][Full Text] [Related]
17. Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.
Elli FM; Barbieri AM; Bordogna P; Ferrari P; Bufo R; Ferrante E; Giardino E; Beck-Peccoz P; Spada A; Mantovani G
Bone; 2013 Oct; 56(2):276-80. PubMed ID: 23796510
[TBL] [Abstract][Full Text] [Related]
18. BMP and mTOR signaling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities?
Wu J; Ren B; Shi F; Hua P; Lin H
J Cell Biochem; 2019 Aug; 120(8):12108-12122. PubMed ID: 30989716
[TBL] [Abstract][Full Text] [Related]
19. Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable.
Al Mukaddam M; Rajapakse CS; Pignolo RJ; Kaplan FS; Smith SE
Bone; 2018 Apr; 109():147-152. PubMed ID: 28822792
[TBL] [Abstract][Full Text] [Related]
20. Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities.
Pacifici M
Curr Opin Pharmacol; 2018 Jun; 40():51-58. PubMed ID: 29614433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
